A 29-year-old man with recently diagnosed HIV infection and a CD4 cell count of
225/mm3 began treatment with atazanavir (300 mg), ritonavir (100 mg),
emtricitabine (200 mg), and tenofovir (300 mg) daily. For 18 months, he was treatment
adherent and his plasma HIV RNA level was below the limit of detection. He then began
a relationship with a new partner, who introduced him to methamphetamines. His
medication adherence became erratic, and he missed appointments in clinic.
Eventually. he was hospitalized for rehabilitation, and he resumed taking his
medications on schedule. Following his discharge, he was found to have a plasma HIV
RNA level of 11,400 copies/ml. Genotypic resistance testing revealed only an M184V
mutation associated with emtricitabine resistance. A decision regarding his next
treatment regimen needs to be made.
Download this citation for these citation managers:
Or, download this citation in these formats:
If you experience problems using these citation formats, send us feedback.